TellBio

TellBio is revolutionizing the detection and treatment of cancer using innovative technology. Current cancer metastasis detection is limited mainly to imaging and invasive biopsies. Using their proprietary circulating tumor cells (CTCs) technology platform, TellBio is detecting and monitoring cancer progression by isolating CTCs from patients’ liquid biopsies through the use of microfluidic tools. TellBio’s approach is agnostic to the primary solid tumor and therefore can be applied for cancers from prostate to breast cancer. Ultimately, TellBio’s technology can be used to advance translational and clinical efforts to improve the lives of cancer patients.

Jobs: